SEROTONERGIC NEUROTRANSMISSION IN THE SPINAL-CORD AND MOTOR CORTEX OFPATIENTS WITH MOTOR-NEURON DISEASE AND CONTROLS - QUANTITATIVE AUTORADIOGRAPHY FOR 5-HT1A AND 5-HT2 RECEPTORS

Citation
V. Forrest et al., SEROTONERGIC NEUROTRANSMISSION IN THE SPINAL-CORD AND MOTOR CORTEX OFPATIENTS WITH MOTOR-NEURON DISEASE AND CONTROLS - QUANTITATIVE AUTORADIOGRAPHY FOR 5-HT1A AND 5-HT2 RECEPTORS, Journal of the neurological sciences, 139, 1996, pp. 83-90
Citations number
29
Categorie Soggetti
Neurosciences
ISSN journal
0022510X
Volume
139
Year of publication
1996
Supplement
S
Pages
83 - 90
Database
ISI
SICI code
0022-510X(1996)139:<83:SNITSA>2.0.ZU;2-6
Abstract
Serotonin 5-HT is a potent modulator of motor neuron excitability in t he spinal cord. Serotonergic neurotransmission, because of its effects on glutamatergic excitation, may be relevant to the pathogenesis and therapy of motor neuron disease (MND). The human motor system was stud ied at two levels, spinal cord and motor cortex, by autoradiography fo r the 5-HT1A and 5-HT2 receptor subclasses. In addition, biochemical e stimations of indole metabolites were performed in the spinal cord. Po st mortem tissue from control cases and MND patients showed a reductio n in 5-HT1A receptor binding in the cervical (p < 0.01) but not lumbar ventral horn in MND. 5-HT2 receptors were preserved in the ventral ho rn at both levels and were focally abundant around motor neuron somata . Tissue levels of 5-HT were unchanged in the spinal cord in MND. The metabolite 5-HIAA was increased in the cervical spinal cord in MND as was the molar ratio of 5HIAA:5-HT, implying that there may be an incre ased turnover of 5HT. In the motor cortex and premotor cortex the 5-HT 1A receptor remained unchanged in MND. There was a 20% reduction in 5- HT2 receptor binding sites (p < 0.05) across all the cortical laminae with preservation of the normal pattern of laminar binding. These chan ges in two levels of the motor system in MND most likely represent phy siological adaptations in the spinal cord and motor cortex rather than primary involvement of the serotonergic system in the pathogenesis of the disease.